INSTADOSE PHARMA (INSD) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 0 5 sessions, November 3, 2025 to January 9, 2026
- Largest daily move
- +0% close of December 12, 2025
- 5-year change
- -99.9% closing prices, January 8, 2021 to January 9, 2026
Company Description
INSTADOSE PHARMA (OTC: INSD) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $585.1K.
INSD has gained 0.0% over the past month. The last closing price was $0.0001.
This page collects what Stock Titan holds for INSD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
INSTADOSE PHARMA (INSD) closed at $0.0001 on January 9, 2026. Over the past month, the price has gained 0.0%.
INSD Metrics & Rankings
Price returns through January 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
INSTADOSE PHARMA has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 1 with negative movement. Key topics include management. View all INSD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
INSD Company Profile & Sector Positioning
INSTADOSE PHARMA (INSD) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing INSD often look at related companies in the same sector, including IONIC BRANDS CORP (IONKF), NEUTRA CORPORATION (NTRR), PHARMAGREEN BIOTECH INC (PHBI), CANNABIS GLOBAL INC (CBGL), and GRAPEFRUIT USA INC (GPFT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate INSD's relative position within its industry.